Taylor James Premer alias Dr. Root-Cause Profit
slangin' hopium at Chiropractic, Functional Medicine, Strength Training in Lincoln, NE in Lincoln, NE
Website · premerhealth.com
Practice location
100
Lincoln, NE 68516
Funnel-first framing that runs on persuasion, light on published evidence.
Oh, Taylor Premer, the 'functional medicine' chiropractor who's so advanced that insurance won't even touch him! He's got the 'root-cause' approach to fix your hormones, gut, and fatigue, all while selling you GI MAP and DUTCH tests that cost a fortune. He's the king of the 'labs are normal but you feel bad' grift, turning your 'gray area' health into his cash-only, HSA-friendly goldmine. Truly, a visionary who's 'beyond the standard playbook'—and way beyond his scope.
High grift signals
Score breakdown
Direct answer
Taylor James Premer is licensed in Nebraska as a chiropractor (DC), not as an MD or DO, and Nebraska's chiropractic scope statute (Nebraska Chiropractic Practice Act (scope limited to musculoskeletal/spine care)) limits that license to musculoskeletal care, not the diagnosis or treatment of systemic disease. Even so, they advertise diagnosing or treating Functional Medicine, Nutrition & supplement protocols, root-cause approach, Root-Cause Care, and Functional Medicine for systemic disease, conditions that belong with appropriately board-certified physicians. Those same pages route patients toward supplements, lab panels, and paid programs that Taylor James Premer profits from.
Key findings
- False Authority: The subject uses the narrow credential of a chiropractor (DC) to claim broad authority as a 'functional medicine provider,' implying competence in diagnosing and treating systemic internal diseases like hormone and gut dysfunction, which is outside their licensed scope.see section ↓
- Claim "functional medicine": mixed in the medical literature.see section ↓
- Claim "Functional lab testing (GI MAP, DUTCH, blood work)": mixed in the medical literature.see section ↓
- NPI registry confirms Taylor Premer as Chiropractor (DC) in Nebraska (NPI 1588146310).see section ↓
- Taylor James Premer shows credential inflation relative to stated vs likely credentials.see section ↓
- Dr Taylor James Premer is marketed with a doctor title, but reviewed credentials indicate Chiropractor (DC) rather than an MD/DO physician license.see section ↓
- Against Nebraska Board of Chiropractic scope rules (Nebraska Chiropractic Practice Act (scope limited to musculoskeletal/spine care)), these advertised activities appear outside Taylor James Premer's license (including conditions they merely list as ones they treat): Functional Medicine,…see section ↓
- 12 of 12 advertised activities fall outside permitted Chiropractor scope in NE.see section ↓
Claims & evidence
7 advertised conditions or treatments fall outside their license scope. Each box leads with state-board scope notation; literature cross-check follows when we matched a specific claim. Every card carries its receipts: the quoted wording, a live source link, and an archived copy.
Taylor James Premer is not licensed or approved by Nebraska Board of Chiropractic to diagnose, treat, or cure Functional Medicine.
Functional Medicine
- Supports
- High-quality evidence specifically testing functional medicine as a distinct model of care is limited but growing, and is largely focused on chronic disease and patient‑reported outcomes rather than hard clinical endpoints or mortality. A large cohort study from the Cleveland Clinic Center for Functional Medicine found that patients receiving functional medicine care had statistically greater improvements in PROMIS Global Physical Health at 6 months compared with propensity‑matched patients in a conventional family health center, suggesting better short‑term quality‑of‑life outcomes, although the differences attenuated by 12 months. [3][6][7] Separate retrospective cohort work on functional medicine–based shared medical appointments (SMAs) in chronic conditions reported greater improvements in health‑related quality of life and modest biometric changes (weight, blood pressure) at 3 months compared with individual functional medicine visits, while also being less costly to deliver. [8] A randomized controlled trial of an elimination diet with versus without functional medicine health coaching in relatively healthy adults showed clinically meaningful within‑group improvements in patient‑reported global physical and mental health in both arms over 10 weeks, with some additional benefit of coaching in those with higher baseline symptom burden. [2][5] Narrative and conceptual papers from proponents argue that functional medicine is aligned with systems biology and evidence‑based lifestyle interventions, and they highlight observational studies where functional medicine programs were associated with improved PROMIS physical and mental health scores, reduced pain, and better outcomes in conditions such as type 2 diabetes, autoimmune thyroid disease, and multiple sclerosis, but these are largely preliminary and not definitive. Overall, there is some supportive evidence that functional medicine–style programs can improve patient‑reported quality of life and symptoms in chronic disease populations, and that team‑based or shared‑visit formats may do so cost‑effectively, but this evidence base is still relatively small, heterogeneous, and heavily centered on one major academic center.
- Contradicts
- There are no large randomized, multicenter trials, high‑quality systematic reviews, or major guideline endorsements showing that functional medicine, as a named model, improves hard clinical outcomes (e. [2] g. , mortality, cardiovascular events, major complications) beyond established evidence‑based care. Existing studies are mostly observational, single‑center, or short‑term, and they focus on self‑reported outcomes, which are susceptible to selection bias, expectation effects, and confounding by patient engagement or socioeconomic status. In the elimination‑diet RCT with functional medicine health coaching, both the coached and self‑guided groups improved substantially, and there was no significant between‑group difference in primary outcomes in the full cohort; advantages of functional medicine coaching appeared only in a more symptomatic subgroup, which raises questions about generalizability and the incremental value of the branded approach. [5][6][7][8] Systematic reviews of integrative or functional‑style care models have found very few rigorous RCTs, small sample sizes, and methodological issues (e. g. , lack of blinding, unclear control conditions), leading to the conclusion that evidence for integrative or functional medicine as a comprehensive model of care remains limited and insufficient for firm claims of superiority over standard medicine. Major evidence‑based guidelines and practice updates in common conditions (e. g. , diverticulitis, primary aldosteronism, cancer, perioperative oncology, neonatal care) are grounded in conventional pharmacologic, surgical, and lifestyle interventions and do not identify “functional medicine” as a recommended or recognized treatment pathway, which indirectly underscores that functional medicine has not met the evidentiary thresholds required for guideline inclusion. [3][4] No major specialty board or national guideline body has formally recognized functional medicine as a medical specialty or subspecialty, and professional societies sometimes criticize it for overuse of non‑validated testing, supplements, and unproven “root‑cause” diagnostics that lack robust clinical trial support. [1] Taken together, the current literature contradicts strong claims that functional medicine is broadly superior, disease‑modifying, or capable of reversing chronic diseases in a way that is clearly beyond optimized evidence‑based conventional care.
- Mainstream view
- Mainstream academic and guideline‑based medicine views functional medicine as a form of integrative or lifestyle‑oriented care that overlaps substantially with accepted practices like nutrition therapy, exercise prescription, and psychosocial support, but it does not regard “functional medicine” itself as an established, evidence‑validated specialty or a clearly superior model of care. [6][7] Conventional guidelines for chronic conditions prioritize interventions supported by high‑quality randomized trials and systematic reviews—such as structured exercise in cancer survivors, evidence‑based pharmacotherapy and surgery in endocrine and cardiovascular disease, and standardized perioperative regimens—and these are recommended regardless of whether they are delivered in a functional medicine clinic or a standard practice. [2][3][4][5][8] [ref:5 Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).
“Functional Medicine”
Rule: Nebraska Chiropractic Practice Act (scope limited to musculoskeletal/spine care)
Taylor James Premer is not licensed or approved by Nebraska Board of Chiropractic to diagnose, treat, or cure Functional lab testing (GI MAP, DUTCH, blood work).
Functional lab testing (GI MAP, DUTCH, blood work)
- Supports
- There is some analytical validation for components of functional lab testing, but high-quality clinical outcome evidence is limited. For the DUTCH dried urine hormone test, a peer‑reviewed validation study reported that the 4‑spot dried urine methodology allows efficient and accurate assessment of numerous urine metabolites compared with standard methods, supporting its analytical reliability as a way to measure hormones and metabolites in urine.[10] This supports the narrow claim that this testing format can quantify certain hormones/metabolites with reasonable technical validity. Conventional blood work ordered in standard medical practice (e.g., basic metabolic panels, lipid panels, thyroid function tests) is extensively validated and underpins major guideline‑based care across almost all specialties, but this relates to standard indications and reference ranges rather than the expanded “functional” interpretation model. Stool‑based molecular assays for infectious diarrhea and colorectal cancer screening (e.g., multiplex PCR panels like BioFire, FIT, and multitarget stool DNA tests) have reasonable sensitivity and high specificity and are supported by randomized trials and large implementation studies for clearly defined indications such as acute infectious diarrhea and colorectal cancer screening in average‑risk adults, indicating that stool testing in general can be clinically valuable when rigorously validated and used according to evidence‑based guidelines.[17][19]
- Contradicts
- The strongest specific evidence addressing a flagship functional test (GI‑MAP) shows serious performance problems. A 2020 evaluation of the GI‑MAP qPCR stool assay against a multiplex PCR reference panel found sensitivity around 80% but specificity only about 26%, with a high rate of false positives even in negative controls, and substantial variability across replicates.[13] The authors concluded that poor specificity and variability could cause clinicians to treat patients for pathogens that were not truly present, directly contradicting claims that GI‑MAP is a reliable, gold‑standard tool for guiding treatment. Subsequent summaries of this work emphasize that GI‑MAP produced false positives in roughly three‑quarters of samples without the target organisms, again indicating that it is not sufficiently accurate for broad diagnostic use or for fine‑grained “dysbiosis” mapping. More broadly, multiple reviews and consensus statements on microbiome and nonstandard stool panels state that, outside of a few specific indications (e.g., C. difficile PCR, FIT or stool DNA for colorectal cancer screening), clinical usefulness of most commercial microbiome/functional stool tests is limited and unproven for routine care; concerns include lack of standardization, poor reproducibility, uncertain clinical thresholds, and risk of overtreatment based on incidental findings. For DUTCH and similar comprehensive hormone metabolite panels, the existing validation literature largely addresses analytical agreement with other laboratory methods rather than demonstrating that using these panels to guide treatment improves patient‑important outcomes in randomized trials; there is no high‑quality evidence that interpreting dozens of hormone metabolites in a “functional” framework leads to better outcomes than standard endocrine work‑ups. Major guidelines in endocrinology and gastroenterology do not recommend GI‑MAP, DUTCH, or broad “functional” panels for the routine evaluation of nonspecific symptoms such as fatigue, bloating, or general “hormone imbalance,” and they warn in general against unvalidated laboratory panels that may lead to overdiagnosis and unnecessary treatment.
- Mainstream view
- The mainstream medical position distinguishes between: (1) standard, guideline‑based blood tests and selected stool/hormone assays that are well validated and clearly linked to clinical decisions, and (2) broad, proprietary “functional” panels such as GI‑MAP and large DUTCH profiles used to search for root causes of nonspecific symptoms. [9][11] For the first group (conventional blood work; validated stool tests like FIT, stool DNA for colorectal cancer screening, or targeted molecular panels for specific gastrointestinal pathogens), there is strong evidence that these tests have acceptable accuracy and improve outcomes when used according to established guidelines, so they are widely recommended for clearly defined indications. [10] For the second group, mainstream bodies view most functional medicine panels as insufficiently validated: analytical performance is often incomplete or problematic (as shown for GI‑MAP), reference ranges and clinical thresholds are not standardized, and there is little or no evidence from randomized trials or high‑quality observational studies that their use leads to better health outcomes compared with thorough history, examination, and standard targeted testing. [12] Mainstream clinicians therefore generally do not recommend routine use of GI‑MAP, DUTCH, or similar expansive functional lab panels for broad screening or for managing common chronic complaints; when they are used, they should be interpreted cautiously, in conjunction with validated tests and clinical judgment, and not as sole determinants of diagnosis or therapy. Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).
“Functional lab testing (GI MAP, DUTCH, blood work)”
Rule: Nebraska Chiropractic Practice Act (scope limited to musculoskeletal/spine care)
Taylor James Premer is not licensed or approved by Nebraska Board of Chiropractic to diagnose, treat, or cure Nutrition & supplement protocols.
Nutrition & supplement protocols
- Supports
- The claim is too vague to be directly supported as written, because it does not specify which nutrition or supplement protocol, target condition, dose, or outcome. One index paper does support a narrow version of the claim: a systematic review and meta-analysis found that community oral nutritional supplement use in oncology patients reduced complications, suggesting that some protocolized supplement strategies can help in specific clinical populations . Another meta-analysis found flaxseed supplements produced blood-pressure reductions in controlled clinical trials, which supports a limited supplement benefit for a defined outcome .
- Contradicts
- The evidence base in the index list does not support a broad, general claim that nutrition and supplement protocols are broadly effective across conditions. The obesity meta-analysis of alpha-lipoic acid does not establish a general protocol effect for weight loss or nutrition management, and its findings were limited to a specific supplement and outcome . The neonatal feeding-protocol meta-analysis is about standardized feeding in NICU care, not general supplement protocols, so it cannot be used to justify a wide claim about nutrition and supplements overall . More generally, supplements often show condition-specific, modest effects, and benefits do not reliably generalize across populations or endpoints.
- Mainstream view
- Mainstream medical and scientific opinion is that nutrition protocols can be beneficial when they are evidence-based, diagnosis-specific, and part of standard care, but blanket claims about supplement protocols are not supported. High-quality evidence supports only certain interventions in certain settings, while many supplements have inconsistent, small, or clinically uncertain effects. Clinicians generally recommend using nutrition and supplementation to correct deficiencies, treat malnutrition, or address specific evidence-based indications rather than as a universal protocol.
“Nutrition & supplement protocols”
Rule: Nebraska Chiropractic Practice Act (scope limited to musculoskeletal/spine care)
Taylor James Premer is not licensed or approved by Nebraska Board of Chiropractic to diagnose, treat, or cure root-cause approach.
root-cause approach
- Supports
- Mainstream evidence-based medicine is conceptually aligned with addressing underlying etiology (root cause) when that etiology is known and modifiable, and many major guidelines and trials embody this principle implicitly. [19] For example, guideline-driven management of hypertension emphasizes accurate diagnosis, distinguishing primary from secondary forms, targeting modifiable causes such as excess dietary salt, obesity, and endocrine disorders, and using therapy tailored to pathophysiology, which is a form of addressing root causes. [13] In clinical nutrition, ASPEN–FELANPE guidelines emphasize identifying underlying disease processes, gastrointestinal function, and malnutrition etiology before initiating parenteral nutrition, including indications such as non-functioning gut or severe malabsorption, which again reflects a root-cause framework. [14][16] ESPEN guidelines for clinical nutrition in inflammatory bowel disease stress controlling gut inflammation and disease activity and correcting specific deficiencies (iron, B12, etc. [15] ), essentially treating causes rather than just symptoms of malnutrition and weight loss. The BMJ systematic review and meta-analysis on human albumin in sepsis evaluates albumin as a pathophysiology-based intervention (volume expansion and oncotic pressure) in septic patients, illustrating how therapies are chosen based on mechanistic causes of shock and capillary leak. [18][20] The randomized trial comparing atenolol versus losartan in Marfan syndrome targets aortic-root enlargement, the root structural cause of lethal dissection, by drugs chosen for their specific impact on aortic wall stress; both treatments reduced aortic root dilatation, demonstrating cause-directed therapy. More broadly, randomized controlled trials and major guidelines integrate causal and mechanistic reasoning (for example, lifestyle modification in hypertension to address the upstream drivers of high blood pressure), so the general principle that identifying and treating root causes can improve outcomes is supported in mainstream evidence-based care. [17]
- Contradicts
- There is little high-quality evidence that a generic, influencer-style “root-cause approach” (especially as used in functional or alternative medicine marketing) is superior to standard guideline-based, evidence-based care, and in many domains the evidence base is weak or absent. [13][19] Commentaries on functional medicine note that although it claims to find root causes, it often relies on unvalidated tests, loosely interpreted “imbalances,” and supplement-heavy regimens that lack robust randomized trial evidence, highlighting a gap between the claim and high-quality data. Outside of specific disease contexts, there are no major randomized trials or meta-analyses demonstrating that a broad root-cause branded model of care consistently improves hard clinical endpoints versus standard care. [14][15] In sepsis, for example, albumin administration is a pathophysiology-based, “root-cause” intervention aimed at intravascular volume and oncotic pressure, yet the BMJ meta-analysis with trial sequential analysis found no significant mortality benefit compared with crystalloids, showing that cause-directed mechanistic plausibility does not guarantee improved outcomes. [18][20] Likewise, guidelines on parenteral nutrition emphasize careful selection based on underlying disease and gut function but also stress that evidence for many proposed indications is limited and that unnecessary PN can cause harm, underscoring that addressing presumed root causes must still be constrained by high-quality outcome data. [16] The Cleveland Clinic functional medicine observational data suggest improvements in patient-reported quality of life but do not provide randomized, controlled evidence that a root-cause branded model is superior to conventional evidence-based care, nor do they establish specific causal pathways for benefit. [17] Overall, where “root-cause approach” is used as a marketing label for broad, intensive testing and alternative regimens, the supporting evidence is sparse, and high-quality comparative trials versus standard guideline-based care are largely lacking.
- Mainstream view
- The mainstream medical position is that clinicians should identify and treat underlying causes of disease when they are known, modifiable, and safely targetable, but interventions must be guided by robust evidence from randomized trials, systematic reviews, and established guidelines, not simply by a generic promise to address root causes. [14][16][17][19] Major guidelines for hypertension, nutrition support, and inflammatory bowel disease all implicitly embody a root-cause logic (accurate diagnosis, distinguishing primary from secondary disease, targeting modifiable risk factors, and tailoring therapy to pathophysiology) but they are cautious, emphasizing proven interventions and recognizing that not all mechanistic or etiologic hypotheses translate into outcome benefit. [15] Mainstream practice therefore supports cause-based care within an evidence-based framework and is skeptical of broad influencer claims that a “root-cause approach” per [13][20]
“our personalized, root-cause approach helps you move better, feel better, and live better”
Rule: Nebraska Chiropractic Practice Act (scope limited to musculoskeletal/spine care)
Taylor James Premer is not licensed or approved by Nebraska Board of Chiropractic to diagnose, treat, or cure Root-Cause Care.
Root-Cause Care
No specific health claims of theirs were cross-checked against the literature.
“Root-Cause Care You Can Trust”
Rule: Nebraska Chiropractic Practice Act (scope limited to musculoskeletal/spine care)
Taylor James Premer is not licensed or approved by Nebraska Board of Chiropractic to advertise Offering 'Functional Medicine' as a service for systemic disease as within their scope of practice.
Offering 'Functional Medicine' as a service for systemic disease
- Supports
- High-quality evidence specifically testing functional medicine as a distinct model of care is limited but growing, and is largely focused on chronic disease and patient‑reported outcomes rather than hard clinical endpoints or mortality. A large cohort study from the Cleveland Clinic Center for Functional Medicine found that patients receiving functional medicine care had statistically greater improvements in PROMIS Global Physical Health at 6 months compared with propensity‑matched patients in a conventional family health center, suggesting better short‑term quality‑of‑life outcomes, although the differences attenuated by 12 months. [3][6][7] Separate retrospective cohort work on functional medicine–based shared medical appointments (SMAs) in chronic conditions reported greater improvements in health‑related quality of life and modest biometric changes (weight, blood pressure) at 3 months compared with individual functional medicine visits, while also being less costly to deliver. [8] A randomized controlled trial of an elimination diet with versus without functional medicine health coaching in relatively healthy adults showed clinically meaningful within‑group improvements in patient‑reported global physical and mental health in both arms over 10 weeks, with some additional benefit of coaching in those with higher baseline symptom burden. [2][5] Narrative and conceptual papers from proponents argue that functional medicine is aligned with systems biology and evidence‑based lifestyle interventions, and they highlight observational studies where functional medicine programs were associated with improved PROMIS physical and mental health scores, reduced pain, and better outcomes in conditions such as type 2 diabetes, autoimmune thyroid disease, and multiple sclerosis, but these are largely preliminary and not definitive. Overall, there is some supportive evidence that functional medicine–style programs can improve patient‑reported quality of life and symptoms in chronic disease populations, and that team‑based or shared‑visit formats may do so cost‑effectively, but this evidence base is still relatively small, heterogeneous, and heavily centered on one major academic center.
- Contradicts
- There are no large randomized, multicenter trials, high‑quality systematic reviews, or major guideline endorsements showing that functional medicine, as a named model, improves hard clinical outcomes (e. [2] g. , mortality, cardiovascular events, major complications) beyond established evidence‑based care. Existing studies are mostly observational, single‑center, or short‑term, and they focus on self‑reported outcomes, which are susceptible to selection bias, expectation effects, and confounding by patient engagement or socioeconomic status. In the elimination‑diet RCT with functional medicine health coaching, both the coached and self‑guided groups improved substantially, and there was no significant between‑group difference in primary outcomes in the full cohort; advantages of functional medicine coaching appeared only in a more symptomatic subgroup, which raises questions about generalizability and the incremental value of the branded approach. [5][6][7][8] Systematic reviews of integrative or functional‑style care models have found very few rigorous RCTs, small sample sizes, and methodological issues (e. g. , lack of blinding, unclear control conditions), leading to the conclusion that evidence for integrative or functional medicine as a comprehensive model of care remains limited and insufficient for firm claims of superiority over standard medicine. Major evidence‑based guidelines and practice updates in common conditions (e. g. , diverticulitis, primary aldosteronism, cancer, perioperative oncology, neonatal care) are grounded in conventional pharmacologic, surgical, and lifestyle interventions and do not identify “functional medicine” as a recommended or recognized treatment pathway, which indirectly underscores that functional medicine has not met the evidentiary thresholds required for guideline inclusion. [3][4] No major specialty board or national guideline body has formally recognized functional medicine as a medical specialty or subspecialty, and professional societies sometimes criticize it for overuse of non‑validated testing, supplements, and unproven “root‑cause” diagnostics that lack robust clinical trial support. [1] Taken together, the current literature contradicts strong claims that functional medicine is broadly superior, disease‑modifying, or capable of reversing chronic diseases in a way that is clearly beyond optimized evidence‑based conventional care.
- Mainstream view
- Mainstream academic and guideline‑based medicine views functional medicine as a form of integrative or lifestyle‑oriented care that overlaps substantially with accepted practices like nutrition therapy, exercise prescription, and psychosocial support, but it does not regard “functional medicine” itself as an established, evidence‑validated specialty or a clearly superior model of care. [6][7] Conventional guidelines for chronic conditions prioritize interventions supported by high‑quality randomized trials and systematic reviews—such as structured exercise in cancer survivors, evidence‑based pharmacotherapy and surgery in endocrine and cardiovascular disease, and standardized perioperative regimens—and these are recommended regardless of whether they are delivered in a functional medicine clinic or a standard practice. [2][3][4][5][8] [ref:5 Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).
“Functional Medicine”
Rule: Nebraska Chiropractic Practice Act (scope limited to musculoskeletal/spine care)
Taylor James Premer is not licensed or approved by Nebraska Board of Chiropractic to advertise Functional Medicine for systemic disease as within their scope of practice.
Functional Medicine for systemic disease
- Supports
- High-quality evidence specifically testing functional medicine as a distinct model of care is limited but growing, and is largely focused on chronic disease and patient‑reported outcomes rather than hard clinical endpoints or mortality. A large cohort study from the Cleveland Clinic Center for Functional Medicine found that patients receiving functional medicine care had statistically greater improvements in PROMIS Global Physical Health at 6 months compared with propensity‑matched patients in a conventional family health center, suggesting better short‑term quality‑of‑life outcomes, although the differences attenuated by 12 months. [3][6][7] Separate retrospective cohort work on functional medicine–based shared medical appointments (SMAs) in chronic conditions reported greater improvements in health‑related quality of life and modest biometric changes (weight, blood pressure) at 3 months compared with individual functional medicine visits, while also being less costly to deliver. [8] A randomized controlled trial of an elimination diet with versus without functional medicine health coaching in relatively healthy adults showed clinically meaningful within‑group improvements in patient‑reported global physical and mental health in both arms over 10 weeks, with some additional benefit of coaching in those with higher baseline symptom burden. [2][5] Narrative and conceptual papers from proponents argue that functional medicine is aligned with systems biology and evidence‑based lifestyle interventions, and they highlight observational studies where functional medicine programs were associated with improved PROMIS physical and mental health scores, reduced pain, and better outcomes in conditions such as type 2 diabetes, autoimmune thyroid disease, and multiple sclerosis, but these are largely preliminary and not definitive. Overall, there is some supportive evidence that functional medicine–style programs can improve patient‑reported quality of life and symptoms in chronic disease populations, and that team‑based or shared‑visit formats may do so cost‑effectively, but this evidence base is still relatively small, heterogeneous, and heavily centered on one major academic center.
- Contradicts
- There are no large randomized, multicenter trials, high‑quality systematic reviews, or major guideline endorsements showing that functional medicine, as a named model, improves hard clinical outcomes (e. [2] g. , mortality, cardiovascular events, major complications) beyond established evidence‑based care. Existing studies are mostly observational, single‑center, or short‑term, and they focus on self‑reported outcomes, which are susceptible to selection bias, expectation effects, and confounding by patient engagement or socioeconomic status. In the elimination‑diet RCT with functional medicine health coaching, both the coached and self‑guided groups improved substantially, and there was no significant between‑group difference in primary outcomes in the full cohort; advantages of functional medicine coaching appeared only in a more symptomatic subgroup, which raises questions about generalizability and the incremental value of the branded approach. [5][6][7][8] Systematic reviews of integrative or functional‑style care models have found very few rigorous RCTs, small sample sizes, and methodological issues (e. g. , lack of blinding, unclear control conditions), leading to the conclusion that evidence for integrative or functional medicine as a comprehensive model of care remains limited and insufficient for firm claims of superiority over standard medicine. Major evidence‑based guidelines and practice updates in common conditions (e. g. , diverticulitis, primary aldosteronism, cancer, perioperative oncology, neonatal care) are grounded in conventional pharmacologic, surgical, and lifestyle interventions and do not identify “functional medicine” as a recommended or recognized treatment pathway, which indirectly underscores that functional medicine has not met the evidentiary thresholds required for guideline inclusion. [3][4] No major specialty board or national guideline body has formally recognized functional medicine as a medical specialty or subspecialty, and professional societies sometimes criticize it for overuse of non‑validated testing, supplements, and unproven “root‑cause” diagnostics that lack robust clinical trial support. [1] Taken together, the current literature contradicts strong claims that functional medicine is broadly superior, disease‑modifying, or capable of reversing chronic diseases in a way that is clearly beyond optimized evidence‑based conventional care.
- Mainstream view
- Mainstream academic and guideline‑based medicine views functional medicine as a form of integrative or lifestyle‑oriented care that overlaps substantially with accepted practices like nutrition therapy, exercise prescription, and psychosocial support, but it does not regard “functional medicine” itself as an established, evidence‑validated specialty or a clearly superior model of care. [6][7] Conventional guidelines for chronic conditions prioritize interventions supported by high‑quality randomized trials and systematic reviews—such as structured exercise in cancer survivors, evidence‑based pharmacotherapy and surgery in endocrine and cardiovascular disease, and standardized perioperative regimens—and these are recommended regardless of whether they are delivered in a functional medicine clinic or a standard practice. [2][3][4][5][8] [ref:5 Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).
“Functional Medicine”
Rule: Neb. Rev. Stat. § 38-807
Manipulation
False Authority
transcript · cited
The subject uses the narrow credential of a chiropractor (DC) to claim broad authority as a 'functional medicine provider,' implying competence in diagnosing and treating systemic internal diseases like hormone and gut dysfunction, which is outside their licensed scope. Likely motive: To attract patients with complex chronic conditions (fatigue, gut issues) who are dissatisfied with standard care, by borrowing the authority of 'functional medicine' to bypass the limitations of a spine-only license.
“Dr. Taylor Premer is a chiropractor and functional medicine provider”
Cherry-Picked Evidence
transcript · cited
This narrative selectively dismisses standard medical lab results as insufficient while promoting 'advanced testing' (GI MAP, DUTCH) as the only truth, creating a false dichotomy that validates the subject's unproven diagnostic methods. Likely motive: To create anxiety about standard care and justify the sale of expensive, non-standard functional lab panels that are not covered by insurance.
“Tired of being told your labs are 'normal' when you feel anything but?”
Fear Mongering
transcript · cited
The content frames the patient's state as a dangerous 'gray area' where standard medicine fails, inducing fear that their condition is being missed and requires the subject's 'deep' intervention. Likely motive: To drive urgency for booking a consultation and purchasing the subject's proprietary testing and treatment plans.
“living in the gray area between 'nothing's wrong' and 'something doesn't feel right'”
Sales Funnel Motive
transcript · cited
The subject explicitly links 'advanced testing' (GI MAP, DUTCH) to 'data-driven protocols' (supplements, nutrition), creating a direct sales funnel where the test is the gateway to selling the treatment. Likely motive: To monetize the entire patient journey: scare content -> abnormal lab result -> proprietary supplement stack -> coaching consult.
“We get to the root using advanced testing, data-driven protocols, and wellness strategies”
Undisclosed Compensation
transcript · cited
While no outbound links were detected in the HTML scan, the explicit promotion of specific commercial lab brands (GI MAP, DUTCH) and 'practitioner-grade' supplements implies a financial relationship (referral fees, dispensing markup) that is not disclosed on the content surface. Likely motive: To avoid FTC scrutiny while generating revenue from lab referrals and supplement dispensing.
“Functional lab testing (GI MAP, DUTCH, blood work)”
Commerce & grift map
The subject uses a 'root-cause' narrative to scare patients about standard care, then directs them to expensive functional lab panels (GI MAP, DUTCH) to find 'abnormalities,' which are then treated with proprietary supplement protocols and coaching. This creates a closed loop of revenue from lab referrals and supplement dispensing, with no disclosure of these financial ties.
GI MAP
Lab testing
Chiropractors often receive referral fees or discounts for ordering GI MAP tests, creating a financial incentive to recommend them.
DUTCH Test
Lab testing
Practicians may receive referral fees or discounts for ordering DUTCH tests, which are not covered by insurance and are expensive.
Vendor provider compensation page (live) · Archive pending
Supplements pitched
- Targeted Supplement Protocols
“Targeted Supplement Protocols: Evidence-based, practitioner-grade support tailored to your lab results and goals”
Labs pitched
- GI MAP
“Functional lab testing (GI MAP, DUTCH, blood work)”
- DUTCH Test
“Functional lab testing (GI MAP, DUTCH, blood work)”
How the money flows
- Lab testing referralUndisclosed Referral fees or discounts for ordering GI MAP and DUTCH tests “Functional lab testing (GI MAP, DUTCH, blood work)”
“Functional lab testing (GI MAP, DUTCH, blood work)”
- In-office dispensing markupUndisclosed Revenue from selling 'practitioner-grade' supplements directly to patients “Targeted Supplement Protocols: Evidence-based, practitioner-grade support”
“Targeted Supplement Protocols: Evidence-based, practitioner-grade support”
- Affiliate / promo linkUndisclosed Outbound commerce store links with strong affiliate or practitioner-markup signals, but no clear FTC-style material-connection disclosure on the page.
Store links detected
- FullscriptHigh likelihood
“Affiliate program language on page”
Sponsors and advertisers
Brands, advertisers, and agencies connected to this content, based on what it promotes and discloses.
Credentials & scope
Glossary: Chiropractor (“Dr.”)
Stated: DR, CHIROPRACTOR · Likely: Chiropractor
Verified against the federal provider registry: DC · Chiropractor · NE license 2224.
Taylor Premer holds a legitimate Doctor of Chiropractic (Chiropractor) degree, but inflates this narrow, musculoskeletal-focused credential to claim broad authority as a 'functional medicine provider' capable of diagnosing and treating systemic internal diseases like hormone and gut dysfunction.
- DC, Doctor of Chiropractic
A state-regulated professional license focused on the diagnosis and treatment of musculoskeletal disorders, primarily the spine. It does not grant a general internal medicine license.
Typically limited to chiropractic adjustments, manual therapy, and rehabilitation for spine and joint pain. Diagnosing or treating systemic diseases (hormones, gut, inflammation) is outside this scope.
Permitted scope vs advertised
Nebraska Board of Chiropractic · Confidence: medium
Nebraska’s chiropractic rules define the practice of chiropractic as diagnosis and treatment of abnormalities of the human body, without drugs or surgery, by adjustment/manipulation and certain related methods. The state’s chiropractic licensure page confirms that anyone practicing chiropractic in Nebraska must be licensed unless a statutory exception applies.[7][5]
What this license permits
- Spinal adjustment and manipulation
- Musculoskeletal evaluation and treatment
- Soft-tissue and rehabilitative care
- Headache care within musculoskeletal scope
12 of 12 advertised activities fall outside permitted scope.
| Advertised | Verdict |
|---|---|
| Listed service Functional Medicine Rule: Nebraska Chiropractic Practice Act (scope limited to musculoskeletal/spine care) Not listed among permitted DC scope activities under the governing practice act. | Outside scope |
| Listed service Functional lab testing (GI MAP, DUTCH, blood work) Rule: Nebraska Chiropractic Practice Act (scope limited to musculoskeletal/spine care) Not listed among permitted DC scope activities under the governing practice act. | Outside scope |
| Listed service Nutrition & supplement protocols Rule: Nebraska Chiropractic Practice Act (scope limited to musculoskeletal/spine care) Not listed among permitted DC scope activities under the governing practice act. | Outside scope |
| root-cause approach Rule: Nebraska Chiropractic Practice Act (scope limited to musculoskeletal/spine care) Not listed among permitted DC scope activities under the governing practice act. | Outside scope |
| Listed service Root-Cause Care Rule: Nebraska Chiropractic Practice Act (scope limited to musculoskeletal/spine care) Not listed among permitted DC scope activities under the governing practice act. | Outside scope |
| Diagnosing systemic internal disease (hormone, gut, inflammation) via functional labs Rule: Nebraska Chiropractic Practice Act (scope limited to musculoskeletal/spine care) | Outside scope |
| Treating 'root causes' of fatigue, gut issues, and behavioral changes Rule: Neb. Rev. Stat. § 38-807 The Nebraska chiropractic materials do not affirmatively authorize treatment of systemic fatigue, gastrointestinal, or behavioral disorders as such, and the practice definition is limited to chiropractic methods without drugs or surgery.[7] | Outside scope |
| Prescribing 'practitioner-grade' supplements as medical treatment for dysfunction Rule: Neb. Rev. Stat. § 38-807 The cited Nebraska chiropractic sources do not affirmatively authorize prescribing supplements as medical treatment, and the statutory practice definition centers on chiropractic methods without drugs or surgery.[7] | Outside scope |
| Offering 'Functional Medicine' as a service for systemic disease Rule: Nebraska Chiropractic Practice Act (scope limited to musculoskeletal/spine care) Using "Functional Medicine" to provide systemic-disease care is not affirmatively authorized in the Nebraska chiropractic rules provided, so it is outside scope under the affirmative-authorization test. | Outside scope |
| Functional Medicine for systemic disease Rule: Neb. Rev. Stat. § 38-807 Nebraska’s chiropractic scope materials do not expressly permit chiropractic management of systemic disease under a functional-medicine framework, so this is out of scope absent specific authorization. | Outside scope |
| GI MAP and DUTCH lab panels for hormone/gut dysfunction Rule: Nebraska Chiropractic Practice Act (scope limited to musculoskeletal/spine care) | Outside scope |
| Root-cause protocols for fatigue and gut issues Rule: Neb. Rev. Stat. § 38-807 The Nebraska sources do not affirmatively authorize chiropractic treatment protocols for fatigue and gut disorders as medical conditions, so this claim is outside the confirmed scope. | Outside scope |
Sources: Chiropractic - DHHS - Nebraska.gov (official), 2023 STATE OF NEBRASKA STATUTES RELATING TO CHIROPRACTIC (official), Title 172, Chapter 29 : Chiropractic (2020) (official), BOARD OF CHIROPRACTIC Nebraska Department of Health and ...
Scope comparison mirror
Side-by-side view of the archived marketing homepage and what a Chiropractor scope permits near Lincoln, NE. Open the mirror for the full comparison: archive on the left, permitted scope and licensed-care paths on the right.
Mirror generated 2026-07-12 13:10 UTC. The archive pane loads styles and images from the intake snapshot.
6 licensed-care paths linked for out-of-scope claims.
When the service is also outside their license
This pattern gets sharper when the service routed to your FSA or HSA also sits outside the practitioner's licensed scope. A provider advertising to diagnose or treat conditions their state board does not authorize is already operating past the edge of their license. Pair that with a cash-pay, FSA or HSA funded model that keeps the work away from any insurer or government program, and there is no claims reviewer, no audit trail, and no payer left to ask whether the care was appropriate or even within the provider's remit. The tax advantaged dollars do the paying, the patient carries the substantiation, and the scope question never reaches anyone with the authority to raise it.
Tip the jar
Report useful? Optional tips help keep scans, archives, and literature cross-checks running. They never change conclusions.
Submission ElPQmbxkqa5YLvC9gQBaU
Fight disinformation
Log a public thread where Taylor James Premer is spreading nonsense, get a copy-paste reply with this report link.
Reply snippets
Before you buy the protocol: Dr. Trust Me Bro fact-checked Taylor James Premer's claims with peer-reviewed sources, https://drtrustmebro.com/analyze/ElPQmbxkqa5YLvC9gQBaU. White-coat charisma isn't evidence.
Full DTMB scan on Taylor James Premer: https://drtrustmebro.com/analyze/ElPQmbxkqa5YLvC9gQBaU
Drop these in YouTube comments, Reddit threads, and forums, link back to this scan, not vibes.
Recent mentions (this doc)
No conversation links logged yet. Be the first above.
Nudge the Doc Bro
We email a public contact address from their site so Taylor James Premer can review this dossier and dispute anything we got wrong.
Know someone who can help?
If you think someone has firsthand information about Taylor James Premer, send them an encouraging note. We email a short, respectful message with this report and clear instructions on how to write in, on the record or anonymously.
Whambulance
Challenge this scan or Wall of Fame entry for Taylor James Premer. Public log, not legal arbitration.
Public challenge log
No posted Wall of Fame challenges linked yet.
Challenges are public on the Wall of Fame card. DTMB does not remove entries for hurt feelings, primary sources or copy corrections only.
File a challenge
Include in your email:
- Doc Bro ID: iGI3cyAJZNktx_1lfb3oa
- Wall entry: /influencer/iGI3cyAJZNktx_1lfb3oa
- Analysis ID: ElPQmbxkqa5YLvC9gQBaU
- Source: https://premerhealth.com/
- Why this entry or scan should change
- Supporting links (one per line)
- Your business email (for verified disputes)
Verified challenges are posted publicly on the report. Public log, not legal arbitration.
Citations
Peer-reviewed and index sources cited in this report.
- [1] AGA Clinical Practice Update on Medical Management of Colonic Diverticulitis: Expert Review.
- [2] Impact of exercise on health outcomes in people with cancer: an umbrella review of systematic reviews and meta-analyses of randomised controlled trials.
- [3] Protocol for treatment of Achilles tendon ruptures; a systematic review with network meta-analysis.
- [4] A Systematic Review Supporting the Endocrine Society Clinical Practice Guideline on Management of Primary Aldosteronism.
- [5] Functional medicine health coaching improved elimination diet compliance and patient-reported health outcomes: Results from a randomized controlled trial
- [6] Association of the Functional Medicine Model of Care With Patient-Reported Health-Related Quality-of-Life Outcomes
- [7] Association of the Functional Medicine Model of Care With Patient-Reported Health-Related Quality-of-Life Outcomes
- [8] Patient outcomes and costs associated with functional medicine-based care in a shared versus individual setting for patients with chronic conditions: a retrospective cohort study
- [9] Reliability of a dried urine test for comprehensive assessment ... - PMC
- [10] Performance of a new molecular assay for the detection ... - PMC - NIH
- [11] Comparison between Go-GutDx, a novel diagnostic stool test kit with potential impact in low-income countries, and BioFire test
- [12] Validity evidence for the new ENDO Mentor Suite and its use in the Fundamentals of Endoscopic Surgery examination
- [13] Guideline-Driven Management of Hypertension: An Evidence-Based Update.
- [14] ASPEN-FELANPE Clinical Guidelines.
- [15] ESPEN guideline: Clinical nutrition in inflammatory bowel disease.
- [16] When Is Parenteral Nutrition Appropriate?
- [17] Beyond Causality: Additional Benefits of Randomized Controlled ...
- [18] NCT00707122 | Volume Replacement With Albumin in Severe Sepsis
- [19] The Integration of Clinical Trials With the Practice of Medicine
- [20] Is Albumin-based Resuscitation in Severe Sepsis and Septic Shock ...